Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.20 (12.12%)
Bid:
1.70
Ask:
2.00
Spread: 0.30 (17.647%)
Market Cap: £296.74k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Board Changes

Today 07:00

RNS Number : 5638K
Iconic Labs PLC
01 July 2026
 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Board Changes

Iconic Labs PLC (LSE: ICON) announces that after more than two years of serving as a Director of the Company, Victor Humberdot is stepping down from this position with immediate effect.

The Company would like to thank Mr Humberdot for his support during this period.

The Company also announces the appointment of Bertalan Jászkuti (aged 52) as Director with immediate effect. Bertalan is a health economist and currently serves as Head of Innovation Funding at Syreon Research Institute Ltd. Prior to his current position, he held senior roles focusing on corporate finance advisory, mergers & acquisitions, fundraising and equity capital market transactions including at Deloitte Advisory and Management Consulting where he was for six years, in addition to his own life-sciences focused boutique investment firm. Over the past 25 years Bertalan has served a wide variety of clients including entrepreneurs seeking sales or fundraising as well as institutional private equity funds, private investors and large multinational companies seeking capital deployment. Bertalan completed all exams at the Chartered Association of Certified Accountants (ACCA) and he holds the ICAEW's Corporate Finance (CF) qualification.

 

For any further information or enquiries please contact:

 

Iconic Labs

John Farquharson, Chief Executive Officer

via Yellow Jersey PR

AlbR Capital Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7469 0930

 

Yellow Jersey PR

Charles Goodwin

Annabelle Wills

 

Tel: +44 (0) 20 3004 9512

 

iconic@yellowjerseypr.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUCAMUPQUAG
Date   Source Headline
29th Apr 201910:14 amRNSTR1 Align Research
26th Apr 201911:05 amRNSHolding(s) in Company
26th Apr 201911:00 amRNSHolding(s) in Company
25th Apr 201910:30 amRNSUpdate on Option
23rd Apr 201911:30 amRNSHolding(s) in Company
17th Apr 201910:05 amRNSHolding(s) in Company
17th Apr 201910:00 amRNSHolding(s) in Company
16th Apr 201912:45 pmRNSHolding(s) in Company
12th Apr 201911:35 amRNSDirector's Interest
12th Apr 201911:30 amRNSHolding(s) in Company
8th Apr 201910:10 amRNSHolding(s) in Company
5th Apr 201912:15 pmRNSHolding(s) in Company
5th Apr 201912:10 pmRNSHolding(s) in Company
3rd Apr 20195:37 pmRNSHolding(s) in Company
2nd Apr 201910:15 amRNSUpdate
21st Mar 20195:02 pmRNSHolding(s) in Company
21st Mar 20195:01 pmRNSUpdate
21st Mar 20195:00 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSOne2One Investor Forum
19th Mar 20191:42 pmRNSHolding(s) in Company
19th Mar 20191:41 pmRNSHolding(s) in Company
18th Mar 20192:05 pmRNSSecond Price Monitoring Extn
18th Mar 20192:00 pmRNSPrice Monitoring Extension
18th Mar 201911:45 amRNSHolding(s) in Company
18th Mar 20199:05 amRNSSecond Price Monitoring Extn
18th Mar 20199:00 amRNSPrice Monitoring Extension
18th Mar 20197:00 amRNSNew Media Business Created
14th Mar 201910:47 amRNSHolding(s) in Company
14th Mar 201910:46 amRNSUpdate
14th Mar 201910:45 amRNSHolding(s) in Company
12th Mar 20197:00 amRNSHolding(s) in Company
11th Mar 20198:48 amRNSHolding(s) in Company
8th Mar 20194:48 pmRNSHolding(s) in Company
8th Mar 20194:47 pmRNSUpdate
8th Mar 20194:46 pmRNSHolding(s) in Company
8th Mar 20194:45 pmRNSHolding(s) in Company
7th Mar 20192:05 pmRNSSecond Price Monitoring Extn
7th Mar 20192:00 pmRNSPrice Monitoring Extension
7th Mar 201911:00 amRNSPrice Monitoring Extension
6th Mar 20194:03 pmRNSUpdate
6th Mar 20192:00 pmRNSPrice Monitoring Extension
5th Mar 201911:05 amRNSSecond Price Monitoring Extn
5th Mar 201911:00 amRNSPrice Monitoring Extension
28th Feb 20192:20 pmRNSHolding(s) in Company
26th Feb 20195:44 pmRNSHolding(s) in Company
25th Feb 20198:12 amRNSDirectorate Change
22nd Feb 20195:50 pmRNSPublication of Prospectus
20th Feb 20194:06 pmRNSHolding(s) in Company
1st Feb 201912:35 pmRNSHolding(s) in Company
24th Jan 20193:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.